ERCC6L2 and acute myeloid leukemia: ERCC excision repair 6 like 2 (ERCC6L2) represents an emerging germline variant recently identified as responsible for BMF syndrome, with relevant clinical implications due to the elevated risk of progression to MDS/AML [13].